Novel markers in the acute coronary syndrome: BNP, IL-6, PAPP-A

Area of Science:

• Cardiology
• Biochemistry
• Inflammation Research

Background:

• Acute coronary syndromes are frequently suspected but rarely confirmed in emergency departments.
• Electrocardiogram (ECG) findings are often inconclusive in patients with acute myocardial infarction (MI).
• Atherosclerosis is recognized as a chronic inflammatory condition, necessitating better diagnostic tools.

Purpose of the Study:

• To investigate novel serum inflammatory markers for improved diagnosis and management of acute coronary events.
• To explore the role of cell adhesion molecules (CAMs) as potential indicators of endothelial dysfunction in cardiovascular disease.

Main Methods:

• Review of current literature on diagnostic challenges in acute coronary events.
• Discussion of emerging inflammatory markers, including cell adhesion molecules (CAMs), intercellular adhesion molecules (ICAMs), and vascular adhesion molecules (VCAMs).
• Focus on CAM expression as a marker for endothelial cell dysfunction.

Main Results:

• A significant majority of patients presenting with suspected acute coronary events do not have the disease.
• A substantial proportion of acute myocardial infarction cases present with nondiagnostic ECG findings.
• Cell adhesion molecules (CAMs) are highlighted as promising markers produced by the arterial wall, indicating endothelial dysfunction.

Conclusions:

• There is a need for more reliable serum markers to enhance the diagnostic accuracy, management, and prognosis of atherosclerosis.
• Emerging inflammatory markers, particularly CAMs, ICAMs, and VCAMs, show potential for future clinical application.
• Continued research into novel cardiac markers is essential for advancing cardiovascular disease diagnostics.